Tom Arneson

573 total citations
17 papers, 429 citations indexed

About

Tom Arneson is a scholar working on Pharmacology, General Health Professions and Psychiatry and Mental health. According to data from OpenAlex, Tom Arneson has authored 17 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in General Health Professions and 4 papers in Psychiatry and Mental health. Recurrent topics in Tom Arneson's work include Cannabis and Cannabinoid Research (7 papers), Bipolar Disorder and Treatment (4 papers) and Pharmaceutical industry and healthcare (2 papers). Tom Arneson is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Bipolar Disorder and Treatment (4 papers) and Pharmaceutical industry and healthcare (2 papers). Tom Arneson collaborates with scholars based in United States, Sweden and Israel. Tom Arneson's co-authors include Dylan M. Zylla, Ellen M. Denzen, Navneet S. Majhail, Lih‐Wen Mau, Wendy L. St. Peter, A.J. Collins, Haifeng Guo, Staffan Selander, Russell V. Luepker and Margareta Troein and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and American Journal of Preventive Medicine.

In The Last Decade

Tom Arneson

17 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Arneson United States 11 190 78 69 69 65 17 429
Candy Wilson United States 16 113 0.6× 35 0.4× 95 1.4× 68 1.0× 12 0.2× 58 938
Olurinde Oni United States 11 168 0.9× 52 0.7× 38 0.6× 49 0.7× 13 0.2× 20 606
Mitchell R. Knisely United States 11 26 0.1× 84 1.1× 37 0.5× 81 1.2× 65 1.0× 46 444
Lenneke Schrier Netherlands 13 25 0.1× 186 2.4× 42 0.6× 33 0.5× 17 0.3× 18 582
Michele Tari Italy 13 53 0.3× 78 1.0× 20 0.3× 34 0.5× 16 0.2× 26 615
Paul Daeninck Canada 17 167 0.9× 170 2.2× 23 0.3× 259 3.8× 9 0.1× 34 785
Eric Hansen United States 8 46 0.2× 40 0.5× 26 0.4× 60 0.9× 10 0.2× 47 633
Jason M. Collins United States 12 33 0.2× 29 0.4× 33 0.5× 146 2.1× 13 0.2× 23 457
Margherita Andretta Italy 12 82 0.4× 31 0.4× 25 0.4× 22 0.3× 6 0.1× 38 441
J.M. Mooy Netherlands 8 31 0.2× 25 0.3× 180 2.6× 109 1.6× 9 0.1× 11 853

Countries citing papers authored by Tom Arneson

Since Specialization
Citations

This map shows the geographic impact of Tom Arneson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Arneson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Arneson more than expected).

Fields of papers citing papers by Tom Arneson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Arneson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Arneson. The network helps show where Tom Arneson may publish in the future.

Co-authorship network of co-authors of Tom Arneson

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Arneson. A scholar is included among the top collaborators of Tom Arneson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Arneson. Tom Arneson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zylla, Dylan M., Grace Gilmore, Gabriela Vazquez‐Benitez, et al.. (2021). A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction. Supportive Care in Cancer. 29(12). 7471–7478. 38 indexed citations
2.
Arneson, Tom, et al.. (2019). A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety. Current Oncology Reports. 21(1). 10–10. 30 indexed citations
3.
Zylla, Dylan M., Grace Gilmore, Gabriela Vazquez‐Benitez, et al.. (2019). A randomized trial of medical cannabis (MC) in patients with advanced cancer (AC) to assess impact on opioid use and cancer-related symptoms.. Journal of Clinical Oncology. 37(31_suppl). 109–109. 2 indexed citations
4.
Zylla, Dylan M., et al.. (2019). Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota’s Medical Cannabis Program. Journal of Oncology Practice. 15(4). e338–e345. 47 indexed citations
5.
Zylla, Dylan M., et al.. (2018). Oncology Clinicians and the Minnesota Medical Cannabis Program: A Survey on Medical Cannabis Practice Patterns, Barriers to Enrollment, and Educational Needs. Cannabis and Cannabinoid Research. 3(1). 195–202. 46 indexed citations
6.
Arneson, Tom, et al.. (2016). Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and Interest Prior to Program Launch.. PubMed. 41(11). 716–722. 39 indexed citations
7.
Arneson, Tom, et al.. (2016). Early Survey Results from the Minnesota Medical Cannabis Program.. PubMed. 99(4). 18–22. 4 indexed citations
8.
Peterson, Todd C., et al.. (2012). Behavior modification after inactivation of cerebellar dentate nuclei.. Behavioral Neuroscience. 126(4). 551–562. 14 indexed citations
9.
Majhail, Navneet S., Lih‐Wen Mau, Ellen M. Denzen, & Tom Arneson. (2012). Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large National Private Claims Database. Bone Marrow Transplantation. 48(2). 294–300. 109 indexed citations
10.
Guo, Haifeng, et al.. (2011). The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients. Nephrology Dialysis Transplantation. 26(9). 2934–2939. 43 indexed citations
11.
Peng, Yuanyuan, Eric D. Weinhandl, Anne Blaes, et al.. (2011). Prevalence of recognized bone metastases in the U.S. adult population.. Journal of Clinical Oncology. 29(15_suppl). 1534–1534. 3 indexed citations
12.
Arneson, Tom, David Zaun, Yi Peng, et al.. (2009). Comparison of methodologies to characterize haemoglobin variability in the US Medicare haemodialysis population. Nephrology Dialysis Transplantation. 24(5). 1378–1383. 15 indexed citations
13.
Arneson, Tom. (2005). Adopting an electronic health record. Keys to success.. PubMed. 88(10). 52–4. 5 indexed citations
14.
Nordin, James D., Sharon J. Rolnick, Ed Ehlinger, et al.. (1998). Lead Levels in High-risk and Low-risk Young Children in the Minneapolis-St Paul Metropolitan Area. PEDIATRICS. 101(1). 72–76. 13 indexed citations
15.
Troein, Margareta, Tom Arneson, Lennart Råstam, et al.. (1996). Reported treatment of hypercholesterolemia by family physicians in Sweden and Minnesota.. PubMed. 11(5). 324–8. 6 indexed citations
16.
Troein, Margareta, Tom Arneson, L. Råstam, et al.. (1995). Reported treatment of hypertension by family physicians in Sweden and Minnesota: a physician survey of practice habits. Journal of Internal Medicine. 238(3). 215–221. 11 indexed citations
17.
Troein, Margareta, Tom Arneson, Lennart Råstam, et al.. (1995). Reported Treatment of Hypercholesterolemia by Family Physicians in Sweden and Minnesota. American Journal of Preventive Medicine. 11(5). 324–327. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Candy Wilson Breakdown of academic impact, for papers by Olurinde Oni Breakdown of academic impact, for papers by Mitchell R. Knisely Breakdown of academic impact, for papers by Lenneke Schrier Breakdown of academic impact, for papers by Michele Tari Breakdown of academic impact, for papers by Paul Daeninck Breakdown of academic impact, for papers by Eric Hansen Breakdown of academic impact, for papers by Jason M. Collins Breakdown of academic impact, for papers by Margherita Andretta Breakdown of academic impact, for papers by J.M. Mooy
Rankless by CCL
2026